Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway
G. Mazzocchi et al., Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway, PEPTIDES, 20(5), 1999, pp. 589-594
Gastric inhibitory polypeptide (GIP) is a 42-amino acid peptide, belonging
to the VIP-secretin-glucagon superfamily, some members of this group are ab
le to regulate adrenocortical function. GIP-receptor mRNA has been detected
in the rat adrenal cortex, but investigations on the effect of GIP on ster
oid-hormone secretion in this species are lacking. Hence, we have investiga
ted the distribution of GIP binding sites in the rat adrenal gland and the
effect of their activation in vivo and in vitro. Autoradiography evidenced
abundant [I-125]GIP binding sites exclusively in the inner adrenocortical l
ayers, and the computer-assisted densitometric analysis of autoradiograms d
emonstrated that. binding was displaced by cold GIP, but not by either ACTH
or the selective ACTH-receptor antagonist corticotropin-inhibiting peptide
(CIP). The intraperitoneal (IP) injection of GIP dose-dependently raised c
orticosterone, but not aldosterone plasma concentration: the maximal effect
ive dose (10 nmol/rat) elicited a twofold increase. GIP did not affect aldo
sterone and cyclic-AMP release by dispersed zona glomerulosa cells. In cont
rast, GIP enhanced basal corticosterone secretion and cyclic-AMP release by
dispersed inner adrenocortical cells in a concentration-dependent manner,
and the maximal effective concentration (10(-7) M) evoked 1.5- and 2.4-fold
rises in corticosterone and cyclic-AMP production, respectively. GIP (10(-
7) M) did not display any additive or potentiating effect on corticosterone
and cyclic-AMP responses to submaximal or maximal effective concentrations
of ACTH. The corticosterone secretagogue action of 10(-7) M CIP was abolis
hed by the protein kinase A (PKA) inhibitor H-89 (10(-5) M), and unaffected
by CIP (10(-6) M). Collectively, these findings indicate that GIP exerts a
moderate but statistically significant stimulatory effect on basal glucoco
rticoid secretion in rats, acting through specific receptors coupled with t
he adenylate cyclase/PKA-dependent signaling pathway. (C) 1999 Elsevier Sci
ence Inc. All rights reserved.